• Nachrichtendetail
• 

13.05.2024 08:22:00 - dpa-AFX: *QIAGEN GETS FDA CLEARANCE FOR QIASTAT-DX RESPIRATORY SYNDROMIC TESTING PANEL FOR ACCURATE RESULTS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	QIAGEN NV EO -,01	A400D5	Frankfurt	40,200	28.05.24 12:24:24	-0,080	-0,20%	0,000	0,000	40,050	40,280